APA (7th ed.) Citation

MK, B., S, S., SW, B., J, R., H, T., S, G., . . . FG, T. (2026). Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: A phase 2/3, observer-masked, randomised, parallel-group trial. The Lancet. Microbe, 101342. https://doi.org/10.1016/j.lanmic.2025.101342

Chicago Style (17th ed.) Citation

MK, Bezabih, et al. "Efficacy of Chloroquine Plus Low-dose Primaquine and Pyronaridine-artesunate Plus Low-dose Primaquine Against Plasmodium Vivax Malaria in Adults and Transmission to Mosquitoes in Ethiopia: A Phase 2/3, Observer-masked, Randomised, Parallel-group Trial." The Lancet. Microbe 2026: 101342. https://doi.org/10.1016/j.lanmic.2025.101342.

MLA (9th ed.) Citation

MK, Bezabih, et al. "Efficacy of Chloroquine Plus Low-dose Primaquine and Pyronaridine-artesunate Plus Low-dose Primaquine Against Plasmodium Vivax Malaria in Adults and Transmission to Mosquitoes in Ethiopia: A Phase 2/3, Observer-masked, Randomised, Parallel-group Trial." The Lancet. Microbe, 2026, p. 101342, https://doi.org/10.1016/j.lanmic.2025.101342.